Department of Radiation Sciences, Institute of Radiation Medicine, Helmholtz Zentrum München GmbH - German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.
Department of Radiation Dosimetry, Nuclear Physics Institute of the CAS, Na Truhlářce 39/64, 180 00, Prague 8, Libeň, Czech Republic.
Sci Rep. 2022 Jun 28;12(1):10909. doi: 10.1038/s41598-022-14149-2.
This study aims to identify key anatomic features that govern the individual variability of lung doses from breast-cancer radiotherapy. 3D conformal, intensity-modulated and hybrid techniques with 50.4 Gy whole-breast dose were planned for 128 patients. From their CT images, 17 anatomic measures were assessed and tested as predictors for lung dose-volume characteristics. Tangential techniques yielded mean ipsilateral lung doses in the range of 3-11 Gy. This inter-patient variability was explained to almost 40% by central lung distance, and to almost 60% if this measure was complemented by midplane lung width and maximum heart distance. Also the variability in further dose-volume metrics such as volume fractions receiving 5, 20 or 40 Gy could be largely explained by the anatomy. Multi-field intensity-modulated radiotherapy reduced high-exposed lung volumes, but resulted in higher mean ipsilateral lung doses and larger low-dose burden. Contralateral lung doses ranged from 0.3 to 1 Gy. The results highlight that there are large differences in lung doses among breast-cancer patients. Most of this inter-individual variability can be explained by a few anatomic features. The results will be implemented in a dedicated software tool to provide personalized estimates of long-term health risks related to breast-cancer radiotherapy. The results may also be used to identify favourable as well as problematic anatomies, and serve as a quick quantitative benchmark for individual treatment plans.
本研究旨在确定控制乳腺癌放射治疗中个体肺剂量差异的关键解剖特征。为 128 名患者规划了 50.4Gy 全乳剂量的 3D 适形、强度调制和混合技术。从他们的 CT 图像中,评估了 17 个解剖学指标,并将其作为肺剂量-体积特征的预测因子进行了测试。切线技术导致同侧肺的平均剂量在 3-11Gy 范围内。这种患者间的变异性可以用中央肺距离解释近 40%,如果将此测量值与中平面肺宽度和最大心脏距离相结合,可以解释近 60%的变异性。进一步剂量-体积指标的变异性,如接受 5、20 或 40Gy 的体积分数,也可以很大程度上用解剖结构来解释。多野强度调制放疗减少了高暴露肺体积,但导致同侧肺平均剂量更高,低剂量负担更大。对侧肺的剂量范围为 0.3-1Gy。结果表明,乳腺癌患者的肺剂量存在很大差异。这种个体间的变异性大部分可以用几个解剖特征来解释。研究结果将被纳入专门的软件工具中,为与乳腺癌放射治疗相关的长期健康风险提供个性化估计。结果还可以用于识别有利和有问题的解剖结构,并作为个体治疗计划的快速定量基准。